论文部分内容阅读
目的:研究探讨CTA、DSA及介入栓塞治疗在颅内动脉瘤中的诊疗价值。方法:回顾性分析100例颅内动脉瘤患者的CTA及DSA资料,其中60例患者进行了介入栓塞治疗。结果:CTA和DSA在颅内动脉瘤检出情况没有差异,P>0.05;对动脉瘤的显示方面DSA优于CTA;60例接受介入栓塞治疗患者中没有出现死亡,4例患者术中出现血管痉挛,在使用药物后缓解,术后DSA检查显示,所有患者的动脉瘤完全栓塞。结论:CTA检查可作为常规筛选颅内动脉瘤的首选方法,在观察动脉瘤大小、形态、载瘤动脉等情况时选择DSA检查效果更好,介入栓塞治疗是一种安全有效的治疗颅内动脉瘤的方法。
Objective: To investigate the clinical value of CTA, DSA and interventional embolization in intracranial aneurysms. Methods: The CTA and DSA data of 100 patients with intracranial aneurysms were retrospectively analyzed. Among them, 60 patients underwent interventional embolization. Results: There was no difference in the detection of intracranial aneurysms between CTA and DSA, P> 0.05; DSA was superior to CTA in displaying aneurysms; no death occurred in 60 patients receiving interventional embolization, and blood vessels occurred in 4 patients Spasms, relieved after medication, and postoperative DSA examination showed complete aneurysm embolism in all patients. Conclusion: CTA can be used as the first choice for screening intracranial aneurysms. It is better to select DSA when observing aneurysm size, morphology, and parent artery, and interventional embolization is a safe and effective treatment for intracranial arteries Tumor method.